Aerovate Therapeutics (AVTE) Institutional Ownership

$20.44
-0.18 (-0.87%)
(As of 05/7/2024 ET)

Institutional Ownership Changes (13F Filings) for Aerovate Therapeutics (NASDAQ:AVTE)

Number of
Institutional Buyers
(last 12 months)
13
Total
Institutional Inflows
(last 12 months)
$63.55M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$6.98M
Get AVTE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AVTE Institutional Buying and Selling by Quarter

Aerovate Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/20/2024Eventide Asset Management LLC12,178$276K0.0%N/A0.044%
2/15/2024Octagon Capital Advisors LP403,685$9.14M1.5%-18.8%1.459%
2/15/2024Parkwood LLC15,786$357K0.0%-23.6%0.057%
2/15/2024Great Point Partners LLC1,037,690$23.48M4.0%-4.9%3.750%
2/14/2024Vestal Point Capital LP400,000$9.05M1.0%N/A1.446%
11/15/2023Alps Advisors Inc.20,395$277K0.0%+11.3%0.074%
11/14/2023Fred Alger Management LLC24,747$336K0.0%-57.2%0.090%
11/13/2023Silverarc Capital Management LLC100,000$1.36M0.4%N/A0.362%
11/13/2023FMR LLC529,544$7.19M0.0%-27.2%1.915%
11/8/2023Swiss National Bank21,201$288K0.0%+30.9%0.077%
9/21/2023Barclays PLC3,406$58K0.0%-27.8%0.012%
8/15/2023HighVista Strategies LLC41,803$717K0.3%+164.0%0.151%
8/14/2023Great Point Partners LLC932,158$15.99M3.1%+23.4%3.377%
8/14/2023TCG Crossover Management LLC2,201,274$37.75M6.2%+103.6%7.976%
8/14/2023Driehaus Capital Management LLC1,194,091$20.48M0.3%N/A4.326%
7/31/2023Strs Ohio2,300$39K0.0%N/A0.008%
6/1/2023Golden State Equity Partners10,530$212K0.1%N/A0.042%
5/16/2023Great Point Partners LLC755,620$15.24M3.0%+99.6%3.046%
5/16/2023 Atlas Venture Life Science Advisors LLC2,039,249$41.13M5.6%+1.1%8.219%
5/16/2023Baker BROS. Advisors LP1,963,479$39.60M0.2%-0.7%7.914%
5/15/2023Ghost Tree Capital LLC200,000$4.03M1.2%+48.1%0.806%
5/12/2023Nan Fung Group Holdings Ltd47,936$967K0.7%-5.3%0.193%
5/11/2023Skandinaviska Enskilda Banken AB publ50,866$1.03M0.0%-4.6%0.205%
3/23/2023MetLife Investment Management LLC5,228$153K0.0%N/A0.021%
2/15/2023Eversept Partners LP91,252$2.67M0.2%N/A0.374%
2/15/2023 Atlas Venture Life Science Advisors LLC2,017,521$59.11M7.1%-13.3%8.265%
2/15/2023Nantahala Capital Management LLC15,700$460K0.0%N/A0.064%
2/14/2023VR Adviser LLC747,869$21.91M3.5%-10.3%3.064%
2/14/2023Parkwood LLC20,560$602K0.1%-3.7%0.084%
2/10/2023Cheyne Capital Management UK LLP18,927$555K1.0%N/A0.078%
2/8/2023Skandinaviska Enskilda Banken AB publ53,340$1.56M0.0%-5.5%0.219%
2/8/2023Swiss National Bank20,701$607K0.0%N/A0.085%
11/15/2022TCG Crossover Management LLC959,572$15.91M4.8%+7.9%3.931%
11/15/2022Citadel Advisors LLC1,615,578$26.79M0.0%+1.5%6.619%
11/14/2022Lynx1 Capital Management LP276,447$4.58M4.1%+44.3%1.133%
11/14/2022Cormorant Asset Management LP2,330,691$38.64M2.7%+34.7%9.548%
11/14/2022Boothbay Fund Management LLC35,757$593K0.0%N/A0.146%
11/14/2022Ergoteles LLC10,574$175K0.0%-41.3%0.043%
11/14/2022VR Adviser LLC833,927$13.83M2.0%+41.2%3.416%
11/14/2022Parkwood LLC21,344$354K0.1%-34.2%0.087%
“Crash Insurance” For Your Retirement (Ad)

When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.

Click here to register for free.
11/14/2022Altium Capital Management LP51,000$846K0.3%N/A0.209%
11/14/2022Ghost Tree Capital LLC150,000$2.49M0.7%N/A0.615%
11/9/2022 Atlas Venture Life Science Advisors LLC2,327,909$38.60M4.3%-11.8%9.537%
11/8/2022New York State Common Retirement Fund7,686$127K0.0%+48.2%0.031%
8/16/2022Parkwood LLC32,414$32K0.1%N/A0.133%
8/4/2022 Chicago Partners Investment Group LLC10,163$226K0.0%N/A0.042%
8/3/2022 Atlas Venture Life Science Advisors LLC2,638,297$41.24M6.9%-15.0%10.808%
7/29/2022Russell Investments Group Ltd.2,056$32K0.0%N/A0.008%
6/30/2022 Amalgamated Bank1,462$27K0.0%N/A0.006%
5/12/2022Penn Mutual Asset Management LLC17,458$320K0.4%N/A0.072%
5/11/2022Skandinaviska Enskilda Banken AB publ14,108$259K0.0%N/A0.058%
5/10/2022Sectoral Asset Management Inc.218,913$4.01M0.7%-22.6%0.897%
5/5/2022New York State Common Retirement Fund12,591$231K0.0%+164.0%0.052%
2/18/2022TCG Crossover Management LLC853,330$10.06M4.7%N/A3.496%
2/14/2022Citadel Advisors LLC1,597,479$18.84M0.0%+0.2%6.544%
2/11/2022Parkwood LLC37,156$438K0.1%-22.7%0.152%
2/3/2022OUP Management Co. LLC603,762$7.12M3.2%N/A2.473%
2/2/2022New York State Common Retirement Fund4,770$56K0.0%+165.0%0.020%
11/16/2021Citadel Advisors LLC1,594,813$32.41M0.0%-1.2%6.533%
11/15/2021Point72 Asset Management L.P.53,872$1.13M0.0%N/A0.221%
11/15/2021Sectoral Asset Management Inc341,367$7.16M0.6%-31.7%1.398%
11/12/2021Geode Capital Management LLC114,423$2.40M0.0%N/A0.469%
11/9/2021BlackRock Inc.483,018$10.13M0.0%N/A1.979%
11/4/2021Deutsche Bank AG5,794$122K0.0%N/A0.024%
11/2/2021New York State Common Retirement Fund1,800$38K0.0%N/A0.007%
10/22/2021Strs Ohio2,300$48K0.0%N/A0.009%
8/17/2021Millennium Management LLC65,043$1.49M0.0%N/A0.281%
8/17/2021Citadel Advisors LLC1,614,998$35.47M0.0%N/A6.989%
8/16/2021Squarepoint Ops LLC9,000$205K0.0%N/A0.039%
8/16/2021RA Capital Management L.P.8,263,982$188.67M3.0%N/A35.762%
8/16/2021Maven Securities LTD9,854$225K0.0%N/A0.043%
8/16/2021Goldman Sachs Group Inc.104,755$2.39M0.0%N/A0.453%
(Data available from 1/1/2016 forward)

AVTE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AVTE shares?

During the previous two years, 38 institutional investors and hedge funds held shares of Aerovate Therapeutics. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($41.13M), Baker BROS. Advisors LP ($39.60M), Cormorant Asset Management LP ($38.64M), TCG Crossover Management LLC ($37.75M), Citadel Advisors LLC ($26.79M), Great Point Partners LLC ($23.48M), and VR Adviser LLC ($21.91M).Learn more on AVTE's institutional investors.

Which institutional investors have been buying Aerovate Therapeutics stock?

Of the 30 institutional investors that purchased Aerovate Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Driehaus Capital Management LLC ($1.19M), TCG Crossover Management LLC ($1.19M), Cormorant Asset Management LP ($600K), Great Point Partners LLC ($553.64K), Vestal Point Capital LP ($400K), VR Adviser LLC ($243.52K), and Ghost Tree Capital LLC ($215K).

How much institutional buying is happening at Aerovate Therapeutics?

Institutional investors have bought a total of 5,003,204 shares in the last 24 months. This purchase volume represents approximately $90.21M in transactions.

Which Aerovate Therapeutics major shareholders have been selling company stock?

Of the 13 institutional investors that sold Aerovate Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Atlas Venture Life Science Advisors LLC ($1.09M), FMR LLC ($198.07K), Octagon Capital Advisors LP ($93.69K), VR Adviser LLC ($86.06K), Sectoral Asset Management Inc. ($63.85K), Great Point Partners LLC ($53.54K), and Fred Alger Management LLC ($33.13K).

How much institutional selling is happening at Aerovate Therapeutics?

Institutional investors have sold a total of 1,661,787 shares in the last 24 months. This volume of shares sold represents approximately $32.61M in transactions.


This page (NASDAQ:AVTE) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners